Report - RISK ASSESSMENT and RISK MITIGATION …...1 1 INTRODUCTION • Pfizer, Inc. submitted a New Drug Application (NDA 21-446) for Lyrica (pregabalin) capsules on October 30, 2003. •

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form